Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of common type 2 diabetes mellitus genetic risk factors in new-onset diabetes after transplantation in kidney transplant patients medicated with tacrolimus.

European journal of clinical pharmacology - 1 Dec 2012

Kurzawski Mateusz, Dziewanowski Krzysztof, Łapczuk Joanna, Wajda Anna, Droździk Marek

Abstract excerpt

PURPOSE: New-onset diabetes after transplantation (NODAT) is a major complication after kidney transplantation. The risk factors for NODAT include the use of calcineurin inhibitors as part of the immunosuppressive regimen, among which tacrolimus has the most pronounced diabetogenic effect. Both NODAT and type 2 diabetes mellitus (T2DM) share several risk factors. Recent studies have identified a number of common...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes Mellitus, Type 2
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Immunosuppressive Agents

Share to Kidney Transplantation

Share to Polymorphism, Single Nucleotide

Share to Risk Factors

Share to Tacrolimus

Source

Open in PubMed Open full text

Identifiers

PMID: 22569928
DOI: 10.1007/s00228-012-1292-8
PMCID: PMC3496482

Genes

HHEX
KCNJ11
PPARG

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of common type 2 diabetes mellitus genetic risk factors in new-onset diabetes after transplantation in kidney transplant patients medicated with tacrolimus.PMID 22569928Read ↗

A HuGE Review and Meta-Analyses of Genetic Associations in New Onset Diabetes after Kidney Transplantation.Semantic proximity Read ↗

Clinical and genetic risk factors for new-onset diabetes mellitus after transplantation (NODAT) in major transplant centres in Malaysia.Semantic proximity Read ↗

KCNQ1 gene variants and risk of new-onset diabetes in tacrolimus-treated renal-transplanted patients.Semantic proximity Read ↗

Single-nucleotide polymorphisms in P450 oxidoreductase and peroxisome proliferator-activated receptor-α are associated with the development of new-onset diabetes after transplantation in kidney transplant recipients treated with tacrolimus.Semantic proximity Read ↗

Association of common type 2 diabetes risk gene variants and posttransplantation diabetes mellitus in renal allograft recipients in Korea.Semantic proximity Read ↗

Genetic risk factors for post-transplantation diabetes mellitus in Chinese Han renal allograft recipients treated with tacrolimus.Semantic proximity Read ↗

Association of transcription factor 7-like 2 (TCF7L2) gene polymorphism with posttransplant diabetes mellitus in kidney transplant patients medicated with tacrolimus.Semantic proximity Read ↗

Pharmacogenetics of post-transplant diabetes mellitus in children with renal transplantation treated with tacrolimus.Semantic proximity Read ↗

Genetic and clinic predictors of new onset diabetes mellitus after transplantation.Semantic proximity Read ↗

Pilot study: association of traditional and genetic risk factors and new-onset diabetes mellitus following kidney transplantation.Semantic proximity Read ↗

New-onset diabetes mellitus after renal transplantation.Semantic proximity Read ↗

CYP3A4 and GCK genetic polymorphisms are the risk factors of tacrolimus-induced new-onset diabetes after transplantation in renal transplant recipients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.